Cibus (NASDAQ:CBUS) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Cibus (NASDAQ:CBUS) from a hold rating to a sell rating in a research report released on Saturday morning,Wall Street Zen reports.

Separately, Weiss Ratings cut Cibus from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Monday, June 29th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Cibus currently has a consensus rating of “Hold” and a consensus price target of $9.00.

Cibus Price Performance

NASDAQ:CBUS opened at $1.56 on Friday. Cibus has a one year low of $1.09 and a one year high of $4.19. The company has a market cap of $119.23 million, a PE ratio of -0.95 and a beta of 1.59. The firm has a 50-day moving average of $1.75 and a 200-day moving average of $1.78.

Cibus (NASDAQ:CBUS) last released its quarterly earnings results on Thursday, August 13th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.19) by ($0.10). The company had revenue of $0.99 million for the quarter, compared to analyst estimates of $1.70 million. Cibus had a negative net margin of 2,258.89% and a negative return on equity of 287.03%. On average, equities research analysts expect that Cibus will post -1.13 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cibus

A number of hedge funds and other institutional investors have recently modified their holdings of the business. Rockland Trust Co. bought a new stake in Cibus during the second quarter worth $41,000. Bank of America Corp DE increased its position in shares of Cibus by 324.2% during the 1st quarter. Bank of America Corp DE now owns 74,358 shares of the company’s stock valued at $147,000 after purchasing an additional 56,830 shares during the last quarter. Weiss Asset Management LP bought a new stake in shares of Cibus during the 1st quarter worth $1,758,000. OMERS ADMINISTRATION Corp bought a new stake in shares of Cibus during the 1st quarter worth $66,000. Finally, Renaissance Technologies LLC boosted its holdings in shares of Cibus by 42.5% in the 1st quarter. Renaissance Technologies LLC now owns 98,900 shares of the company’s stock worth $196,000 after buying an additional 29,500 shares during the last quarter. Hedge funds and other institutional investors own 33.81% of the company’s stock.

About Cibus

Cibus, Inc is an agricultural biotechnology company that develops gene-edited traits for crops. Its technology is designed to make targeted changes to plant genetics without introducing foreign DNA, with the goal of improving crop performance, productivity and sustainability.

The company’s proprietary Rapid Trait Development System (RTDS) platform is used to develop traits for the global seed industry. Cibus has focused on crops including canola, soybean and rice, pursuing applications such as improved disease resistance, herbicide tolerance, reduced pod shatter and other traits intended to support farmers and seed companies.

Founded in 2001, Cibus became a publicly traded company following its 2023 merger with Calyxt, Inc The company is headquartered in San Diego, California, and works with agricultural and seed-industry partners to advance and commercialize gene-edited crop traits.